Chicago Equity Partners’s Synergy Pharmaceuticals SGYP Stock Holding History
Bought
Maintained
Sold
Other funds holding SGYP
OCM
Chicago Equity Partners's SGYP Position: Q4 2018 in Review
Chicago Equity Partners sold out of Synergy Pharmaceuticals (SGYP) in Q4 2018, closing a stake of 472,535 shares — an estimated $803K sold.
Chicago Equity Partners first reported a position in SGYP in Q1 2017 and held it in 3 quarters. The position peaked at $803K in Q3 2018. 89 funds tracked by Wall St. Rank hold SGYP as of Q4 2018.
- Chicago Equity Partners reported no remaining Synergy Pharmaceuticals position as of Q4 2018 after selling out during the quarter.
- Chicago Equity Partners sold 472,535 Synergy Pharmaceuticals shares in Q4 2018, an estimated $803K.
- Chicago Equity Partners first reported a position in Synergy Pharmaceuticals in Q1 2017 and held it in 3 quarters.
- Chicago Equity Partners's Synergy Pharmaceuticals position peaked at $803K in Q3 2018.
- 89 funds tracked by Wall St. Rank held Synergy Pharmaceuticals as of Q4 2018.
Based on Chicago Equity Partners's 13F filing for Q4 2018, filed 5 Feb 2019.